These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10899255)

  • 21. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.
    Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Marcus SL; Stoddard CJ; Johnson AG; Reed MW
    Gut; 2000 Nov; 47(5):612-7. PubMed ID: 11034574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy.
    Mackenzie GD; Dunn JM; Selvasekar CR; Mosse CA; Thorpe SM; Novelli MR; Bown SG; Lovat LB
    Lasers Med Sci; 2009 Sep; 24(5):729-34. PubMed ID: 19057983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy.
    Davila ML
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer.
    Overholt BF; Panjehpour M
    Gastrointest Endosc; 1995 Jul; 42(1):64-70. PubMed ID: 7557181
    [No Abstract]   [Full Text] [Related]  

  • 26. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.
    Hage M; Siersema PD; van Dekken H; Steyerberg EW; Haringsma J; van de Vrie W; Grool TE; van Veen RL; Sterenborg HJ; Kuipers EJ
    Gut; 2004 Jun; 53(6):785-90. PubMed ID: 15138203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
    Ortner M; Lochs H
    Z Gastroenterol; 1998 Jan; 36(1):111-3. PubMed ID: 9531692
    [No Abstract]   [Full Text] [Related]  

  • 28. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
    Hinnen P; de Rooij FW; Hop WC; Edixhoven A; van Dekken H; Wilson JH; Siersema PD
    J Photochem Photobiol B; 2002 Aug; 68(1):8-14. PubMed ID: 12208031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus.
    Mackenzie GD; Jamieson NF; Novelli MR; Mosse CA; Clark BR; Thorpe SM; Bown SG; Lovat LB
    Lasers Med Sci; 2008 Apr; 23(2):203-10. PubMed ID: 17610005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of photodynamic therapy in Barrett's esophagus: A review.
    Overholt BF
    Can J Gastroenterol; 1999 Jun; 13(5):393-6. PubMed ID: 10377469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic therapy of Barrett's: what more do we need to know?
    Van Laethem JL; Devière J
    Gut; 2004 Jun; 53(6):779-80. PubMed ID: 15138200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
    Pech O; Nagy CD; Gossner L; May A; Ell C
    Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on endoscopic eradication of Barrett's esophagus: who are appropriate candidates and what is the best method?
    Fennerty MB
    Gastrointest Endosc; 1999 Mar; 49(3 Pt 2):S24-8. PubMed ID: 10049444
    [No Abstract]   [Full Text] [Related]  

  • 35. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
    Dunn J; Lovat L
    Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus.
    van den Boogert J; Houtsmuller AB; de Rooij FW; de Bruin RW; Siersema PD; van Hillegersberg R
    Lasers Surg Med; 1999; 24(1):3-13. PubMed ID: 10037346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid.
    van Veen RL; Aalders MC; Pasma KL; Siersema PD; Haringsma J; van de Vrie W; Gabeler EE; Robinson DJ; Sterenborg HJ
    Lasers Surg Med; 2002; 31(5):299-304. PubMed ID: 12430146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of photodynamic therapy in the esophagus.
    Gross SA; Wolfsen HC
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.